Cambridge, MA, United States of America

Sarah Kathleen Knutson

This inventor holds 31 USPTO granted patents and 30 published patent applications, plus 5 CIPO patents and 12 EPO patents, primarily in Cancer Treatment. Top assignees: Epizyme, Inc., Eisai R&d Management Co., Ltd.. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sarah Kathleen Knutson. Retrieved from https://idiyas.com/inventor/sarah-kathleen-knutson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.5

ph-index = 13

Forward Citations = 493(Granted Patents)


Location History:

  • Cambridge, MA (US) (2014 - 2019)
  • Lincoln, MA (US) (2019 - 2024)

Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
EZH2 Inhibitors
Cancer Therapy
Aryl Compounds
Heteroaryl Compounds
Combination Therapy
Lymphoma Treatment
Human EZH2
Benzene Compounds
Dihydropyridin-2-One
Methods of Use
31 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I am happy to assist you in crafting an article about inventor Sarah Kathleen Knutson.

Title: Sarah Kathleen Knutson: Leading the Way in Innovation and Invention

Introduction:

Sarah Kathleen Knutson, a visionary inventor based in Cambridge, MA, is a true trailblazer in the realm of invention. With a deep passion for innovation and a relentless dedication to pushing the boundaries of technology, she continues to inspire the next generation of inventors and shape the future of technology.

Latest Patents:

With an impressive portfolio of 26 patents, Sarah Kathleen Knutson's latest inventions include a "Method for treating cancer" and "EZH2 Inhibitors for treating lymphoma." These groundbreaking pharmaceutical compositions and treatment methods showcase her commitment to advancing cancer therapy.

Career Highlights:

Sarah Kathleen Knutson has made significant contributions to the field of invention through her work at Epizyme, Inc., and Eisai R&D Management Co., Ltd. Her innovative thinking and collaborative efforts have led to the development of novel technologies that have the potential to revolutionize the healthcare industry.

Collaborations:

Throughout her career, Sarah Kathleen Knutson has collaborated with esteemed professionals in the field, including Heike Keilhack and Kevin Wayne Kuntz. These collaborations have not only enhanced the quality of her inventions but have also fostered a culture of innovation and excellence.

Conclusion:

In conclusion, Sarah Kathleen Knutson's exceptional talent, coupled with her unwavering commitment to innovation, has established her as a pioneering force in the world of invention. Her contributions to the field continue to inspire and shape the future of technology, making her a true luminary in the realm of innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…